FORTUNOFF GREGORY 4
4 · Medite Cancer Diagnostics, Inc. · Filed May 8, 2018
Insider Transaction Report
Form 4
FORTUNOFF GREGORY
Director
Transactions
- Purchase
Common Stock
2018-04-04$0.75/sh+1,333,334$1,000,001→ 1,533,334 total - Purchase
Secured Convertible Note
2018-02-04$0.07/sh+100,000$7,500→ 100,000 totalExercise: $0.07From: 2018-08-04Exp: 2020-02-04→ Common Stock (1,333,334 underlying)